Ginkgo Bioworks Holdings, Inc. (DNA) Revenue History
Ginkgo Bioworks Holdings, Inc. (DNA) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $313.84M |
| 2022-12-31 | $477.71M |
| 2023-12-31 | $251.46M |
| 2024-12-31 | $227.04M |
| 2025-12-31 | $170.16M |
How DNA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | $218.71M |
| RGNX | REGENXBIO Inc. | $170.44M |
| STIM | Neuronetics Inc. | $149.16M |
| OSUR | OraSure Technologies Inc. | $115.02M |
| AGEN | Agenus Inc. | $114.20M |
These are five companies in the same sector as DNA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ginkgo Bioworks Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("DNA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DNA | $7.21 | -3.99% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 |